Position
Compound Planning, Inc. in Edwards Lifesciences Corp
Back to the book · All holders of EW
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$20.3K$85.25 → $80.08
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 3.92K | $334.3K | — | — | — | 0.0% |
| Q1 2026 | 5.95K | $476.6K | $80.08 | −$20.3K | $162.6K | 0.0% |